BioRestorative Therapies

BRTX63

Penny Stock

$1.45arrow_drop_down4.63%-$0.07

Penny Stock

BRTX63

$1.45

arrow_drop_down4.63%-$0.07

Penny Stock

Performance History

Key Stats
Open	$1.53
Prev. Close	$1.51
EPS	-0.87
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$10.03M
PE Ratio	-

	LOW	HIGH
Day Range	1.43	1.57
52 Week Range	1.03	3.66

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.87

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About BioRestorative Therapies (BRTX)

BioRestorative Therapies, Inc. (BRTX) is a healthcare company focused on developing regenerative therapies to combat various diseases and injuries. The company is dedicated to improving the quality of life for patients through cutting-edge treatments and technologies. With a strong commitment to innovation, BioRestorative Therapies aims to address unmet medical needs and provide novel solutions for patients worldwide. As a leader in the field of regenerative medicine, the company's research focuses on stem cell-based therapies, tissue engineering, and other advanced treatment modalities.

BioRestorative Therapies' stock price history reflects the company's growth and progress in the healthcare industry. Investors have been drawn to the company's potential for disruptive therapies and its dedication to improving patient outcomes. The stock has shown volatility at times, as is common with biotech companies, but has also seen significant gains during periods of positive news and developments.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Lance Alstodt
Headquarters: Melville
Employees: 10
Exchange: NASDAQ

add BioRestorative Therapies to watchlist

Keep an eye on BioRestorative Therapies

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is BioRestorative Therapies's (BRTX) price per share?

The current price per share for BioRestorative Therapies (BRTX) is $1.45. The stock has seen a price change of -$0.07 recently, indicating a -4.64% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for BioRestorative Therapies (BRTX)?

For BioRestorative Therapies (BRTX), the 52-week high is $3.67, which is 153.1% from the current price. The 52-week low is $1.03, the current price is 40.78% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is BioRestorative Therapies (BRTX) a growth stock?

BioRestorative Therapies (BRTX) has shown an average price growth of -6.65% over the past three years. It has received a score of 9 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying BioRestorative Therapies as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is BioRestorative Therapies (BRTX) stock price performance year to date (YTD)?

As of the latest data, BioRestorative Therapies (BRTX) has a year-to-date price change of -15.7%. Over the past month, the stock has experienced a price change of -16.18%. Over the last three months, the change has been -8.81%. Over the past six months, the figure is 5.07%.

help

Is BioRestorative Therapies (BRTX) a profitable company?

BioRestorative Therapies (BRTX) has a net income of -$10.42M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -979.02% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 21.7%, providing insight into the company's sales performance and growth. Operating income is noted at -$15.22M. Furthermore, the EBITDA is -$11.9M.

help

What is the market capitalization of BioRestorative Therapies (BRTX)?

BioRestorative Therapies (BRTX) has a market capitalization of $10.03M. The average daily trading volume is 1.5, indicating the stock's liquidity and investor engagement.